Prakt. lékáren. 2018; 14(3): 115-118 | DOI: 10.36290/lek.2018.022

Therapy of acute upper respiratory tract infections

Petr Schalek
Otorinolaryngologická klinika FN Královské Vinohrady a 3. LF UK, Praha

Acute upper respiratory tract infections affect both children and adults and for their frequency represent a serious health andsocio-economic problem. The main goal of treatment for these infections is to alleviate symptoms, shorten the duration of illness,avoid complications, and reduce school or work absenteeism. The following brief overview lists the groups of drugs that are oftenrecommended or prescribed for patients with acute upper respiratory infections, with an emphasis on evidence-based medicine.

Keywords: upper respiratory tract infections, common cold, evidence based medicine

Published: October 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Schalek P. Therapy of acute upper respiratory tract infections. Praktické lékárenství. 2018;14(3):115-118. doi: 10.36290/lek.2018.022.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kaňa R. Akutní rinosinusitida. In: Schalek P a kol. Rinosinusitidy, Mladá Fronta 2016: 55-85.
    2. Singh M. Heated, humidified air for the common cold. Cochrane Database Syst Rev 2013; CD001728. DOI: 10.1002/14651858.CD001728.pub5. Go to original source...
    3. Fokkens WJ, Lund VJ, Mullol J et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinology 2012; Suppl 23/2012: 1-299.
    4. Fokkens WJ, Hofmans R, Thomas M. Avoid prescribing antibiotics in acute rhinosinusitis. BMJ. 2014; 349: g5703. Go to original source... Go to PubMed...
    5. Timmer A, Günther J, et al. Pelargonium sidoides extract for treating acute respirátory tract infections (Review). Cochrane Database Syst Rev 2013; CD006323.DOI: 10.1002/14651858.CD006323.pub3. Go to original source...
    6. Balli F, Bergamini B, et al. Clinical effects of erdosteine in the treatmentof acute respiratory tract diseases in children. International Journal of Clinical Pharmacology and Therapeutics 2007; 45(1): 16-22. Go to original source...
    7. Braga PC, Dal Sasso M, et al. Effect of erdosteine and its metabolites on bacterial adhesiveness. Arzneim. - Forsch. Drug Res 1999; 45(1): 344-350.
    8. Busin S, Clerici R, et al. Erdosteine: evaluation of mucorheological and secretory parametres in patients with bronchial phlogistic pathology. Med Praxis 1991; 12(4): 197-205.
    9. Dal Sasso M, Bovio C. The combination of SH metabolite of erdosteine (a mucoactive drug) and ciprofloxacin increases the inhibition od bacterial adhesiveness achieved by ciprofloxacine alone. Drugs Exptl Clin Res 2002; 28(2/3): 75-82.
    10. Fashner J, Ericson K, et al. Treatment of the comon cold in children and adults. Am Fam Physician 2012; 86(2): 153-159. Go to PubMed...
    11. Hayward G, Thompson MJ. Corticosteroids for the common cold (Review). Cochrane Database of Syst Rev 2015; CD008116.DOI: 10.1002/14651858.CD008116.pub3. Go to original source... Go to PubMed...
    12. King D, Mitchell B, et al. Saline nasal irrigation for acute upper respiratory tract infections (Review).) . Cochrane Database of Syst Rev 2015; CD006821.DOI: 10.1002/14651858.CD006821.pub3. Go to original source... Go to PubMed...
    13. Li S, Yue J, et al. Acetaminophen (paracetamol) for the common cold in adults (Review). Cochrane Database Syst Rev 2013; CD008800.DOI: 10.1002/14651858.CD008800.pub2. Go to original source...
    14. Taverner D, Latte J. Nasal decongestants for the common cold. Cochrane Database Syst Rev. 2007; CD001953. Go to original source...
    15. De Sutter AIM, Saraswat A, et al. Antihistamines for the common cold (Review). Cochrane Database Syst Rev 2015; CD009345.DOI: 10.1002/14651858.CD009345.pub2. Go to original source...

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.